192 related articles for article (PubMed ID: 21543988)
1. A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.
Gallione CJ; Solatycki A; Awad IA; Weber JL; Marchuk DA
Genet Med; 2011 Jul; 13(7):662-6. PubMed ID: 21543988
[TBL] [Abstract][Full Text] [Related]
2. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
3. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population.
Yang C; Zhao J; Wu B; Zhong H; Li Y; Xu Y
J Mol Neurosci; 2017 Jan; 61(1):8-15. PubMed ID: 27649701
[TBL] [Abstract][Full Text] [Related]
5. Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.
Bargal R; Avidan N; Olender T; Ben Asher E; Zeigler M; Raas-Rothschild A; Frumkin A; Ben-Yoseph O; Friedlender Y; Lancet D; Bach G
Hum Mutat; 2001 May; 17(5):397-402. PubMed ID: 11317355
[TBL] [Abstract][Full Text] [Related]
6. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
Peretz H; Mulai A; Usher S; Zivelin A; Segal A; Weisman Z; Mittelman M; Lupo H; Lanir N; Brenner B; Shpilberg O; Seligsohn U
Blood; 1997 Oct; 90(7):2654-9. PubMed ID: 9326232
[TBL] [Abstract][Full Text] [Related]
7. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
8. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
9. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
Roa BB; Savino CV; Richards CS
Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
[TBL] [Abstract][Full Text] [Related]
10. A common founder mutation of CERKL underlies autosomal recessive retinal degeneration with early macular involvement among Yemenite Jews.
Auslender N; Sharon D; Abbasi AH; Garzozi HJ; Banin E; Ben-Yosef T
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5431-8. PubMed ID: 18055789
[TBL] [Abstract][Full Text] [Related]
11. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
12. Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.
Edelmann L; Wasserstein MP; Kornreich R; Sansaricq C; Snyderman SE; Diaz GA
Am J Hum Genet; 2001 Oct; 69(4):863-8. PubMed ID: 11509994
[TBL] [Abstract][Full Text] [Related]
13. The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.
Quintana-Murci L; Gal I; Bakhan T; Quach H; Sayar SH; Shiri-Sverdlov R; Baruch RG; McElreavey K; Dagan E; Narod S; Friedman E
Fam Cancer; 2005; 4(2):85-8. PubMed ID: 15951957
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins.
Ah Mew N; Hamel N; Galvez M; Al-Saffar M; Foulkes WD
Clin Genet; 2002 Aug; 62(2):151-6. PubMed ID: 12220453
[TBL] [Abstract][Full Text] [Related]
15. A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population.
Anderson SL; Jalas C; Fedick A; Reid KF; Carpenter TO; Chirnomas D; Treff NR; Ekstein J; Rubin BY
Clin Genet; 2015 Jul; 88(1):74-9. PubMed ID: 24989235
[TBL] [Abstract][Full Text] [Related]
16. A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: A novel founder mutation in Ashkenazi Jews.
Lerer I; Sagi M; Ben-Neriah Z; Wang T; Levi H; Abeliovich D
Hum Mutat; 2001 Nov; 18(5):460. PubMed ID: 11668644
[TBL] [Abstract][Full Text] [Related]
17. Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder.
Rosenberg N; Yatuv R; Orion Y; Zivelin A; Dardik R; Peretz H; Seligsohn U
Blood; 1997 May; 89(10):3654-62. PubMed ID: 9160670
[TBL] [Abstract][Full Text] [Related]
18. Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism.
Glaser B; Furth J; Stanley CA; Baker L; Thornton PS; Landau H; Permutt MA
Hum Mutat; 1999; 14(1):23-9. PubMed ID: 10447255
[TBL] [Abstract][Full Text] [Related]
19. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
20. Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals.
Kaufman B; Laitman Y; Gronwald J; Lubinski J; Friedman E
Genet Test Mol Biomarkers; 2009 Aug; 13(4):465-9. PubMed ID: 19594371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
